Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia-Reference-Cited by-同舟云学术

Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia

Published:2022-05-28 Issue:8 Volume:78 Page:1249-1259
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Yaowaluk Thitipon,Senanarong Vorapun,Limwongse Chanin,Boonprasert Rasda,Bunditvorapoom Duangkamon,Kaewsutthi Supannee,Kijsanayotin Pornpimol^ORCID

Funder

Chulalongkorn University

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-022-03322-1.pdf

Reference29 articles.

1. Noetzli M, Eap CB (2013) Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer’s disease. Clin Pharmacokinet 52(4):225–241. https://doi.org/10.1007/s40262-013-0038-9

2. Rungsanpanya T, Muangpaisan W, Praditsuwan R (2012) Clinical practice with antidementia drugs in a geriatric clinic. J Med Assoc Thailand = Chotmaihet thangphaet 95(8):1081–1089

3. Cacabelos R, Torrellas C, Carrera I (2015) Opportunities in pharmacogenomics for the treatment of Alzheimer’s disease. Future Neurol 10(3):229–252. https://doi.org/10.2217/fnl.15.12

4. Jann MW, Shirley KL, Small GW (2002) Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet 41(10):719–739. https://doi.org/10.2165/00003088-200241100-00003

5. Suwannasri P, Thongnoppakhun W, Pramyothin P, Assawamakin A, Limwongse C (2011) Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais. Clin Biochem 44(13):1144–1152. https://doi.org/10.1016/j.clinbiochem.2011.06.985